Starpharma Holdings Limited (AU:SPL) has released an update.
Starpharma Holdings Limited reported a significant 132% increase in revenue to $9.76 million for the year ending June 2024, boosted by a one-off settlement with Mundipharma, but saw a decrease in adjusted revenue by 24% to $3.2 million when excluding this event. Losses from operations after tax decreased by 48% to $8.16 million, reflecting a tighter control over expenses. No dividends were paid or declared during the period, and the company’s net tangible asset backing per share decreased slightly from $0.08 to $0.07.
For further insights into AU:SPL stock, check out TipRanks’ Stock Analysis page.
